ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oxford Biodynamics Plc

Oxford Biodynamics Plc (OBD)

1.1725
-0.08
(-6.39%)
Closed 21 December 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.1725
Bid
1.15
Offer
1.195
Volume
4,018,338
1.15 Day's Range 1.395
0.90 52 Week Range 36.50
Market Cap
Previous Close
1.2525
Open
1.375
Last Trade Time
Financial Volume
49,747p
VWAP
1.238
Average Volume (3m)
4,614,101
Shares Outstanding
311,860,000
Dividend Yield
-
PE Ratio
-0.33
Earnings Per Share (EPS)
-0.03
Revenue
1.34M
Net Profit
-10.83M

About Oxford Biodynamics Plc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Oxford, Gbr
Founded
-
Oxford Biodynamics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 1.25p. Over the last year, Oxford Biodynamics shares have traded in a share price range of 0.90p to 36.50p.

Oxford Biodynamics currently has 311,860,000 shares in issue. The market capitalisation of Oxford Biodynamics is £3.91 million. Oxford Biodynamics has a price to earnings ratio (PE ratio) of -0.33.

OBD Latest News

Oxford BioDynamics PLC Shareholder Loan and Related Party Transaction

Oxford BioDynamics PLC 19 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Shareholder Loan and Related Party Transaction  ...

Oxford BioDynamics PLC Directorate Change, Funding Update & Joint Broker

Oxford BioDynamics PLC 16 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Board Changes Update on Funding Appointment of Joint...

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 06 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

Oxford BioDynamics PLC Response to Share Price Movement

Oxford BioDynamics PLC 03 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Response to Share Price Movement   Oxford, UK - 3...

Oxford BioDynamics PLC Director/PDMR Shareholding

Oxford BioDynamics PLC 29 November 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

Oxford BioDynamics PLC Director / PDMR holdings and Total Voting Rights

Oxford BioDynamics PLC 28 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

Oxford BioDynamics PLC Prognostic Covid Severity Test Study Published

Oxford BioDynamics PLC 25 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch Prognostic Covid Severity Test Study Published...

Oxford BioDynamics PLC CiRT Receives Clinical Approval from NYS CLEP

Oxford BioDynamics PLC 22 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch® CiRT Receives Clinical Approval from  New York...

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 15 October 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

Oxford BioDynamics pledges to cut costs amid need to raise extra funds

Oxford BioDynamics PLC on Monday launched a strategic review after warning it would need additional cash resources by ...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0275-2.291666666671.21.3950.923471831.06434214DE
4-0.0925-7.312252964431.2652.20.922101011.43321203DE
12-2.0675-63.81172839513.243.90.946141011.38026807DE
26-5.0275-81.08870967746.28.40.928038762.21336496DE
52-24.8275-95.49038461542636.50.918606585.01938975DE
156-33.8275-96.6535510.996487712.78772399DE
260-103.8275-98.88333333331051250.962464517.06940142DE

OBD - Frequently Asked Questions (FAQ)

What is the current Oxford Biodynamics share price?
The current share price of Oxford Biodynamics is 1.1725p
How many Oxford Biodynamics shares are in issue?
Oxford Biodynamics has 311,860,000 shares in issue
What is the market cap of Oxford Biodynamics?
The market capitalisation of Oxford Biodynamics is GBP 3.91M
What is the 1 year trading range for Oxford Biodynamics share price?
Oxford Biodynamics has traded in the range of 0.90p to 36.50p during the past year
What is the PE ratio of Oxford Biodynamics?
The price to earnings ratio of Oxford Biodynamics is -0.33
What is the cash to sales ratio of Oxford Biodynamics?
The cash to sales ratio of Oxford Biodynamics is 2.67
What is the reporting currency for Oxford Biodynamics?
Oxford Biodynamics reports financial results in GBP
What is the latest annual turnover for Oxford Biodynamics?
The latest annual turnover of Oxford Biodynamics is GBP 1.34M
What is the latest annual profit for Oxford Biodynamics?
The latest annual profit of Oxford Biodynamics is GBP -10.83M
What is the registered address of Oxford Biodynamics?
The registered address for Oxford Biodynamics is 3140 ROWAN PLACE, JOHN SMITH DRIVE, OXFORD BUSINESS PARK SOUTH, OXFORD, OX4 2WB
What is the Oxford Biodynamics website address?
The website address for Oxford Biodynamics is www.oxfordbiodynamics.com
Which industry sector does Oxford Biodynamics operate in?
Oxford Biodynamics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
3.41M
BAYBay Capital Plc
5.50p
(19.57%)
209.68k
MASTMast Energy Developments Plc
0.19p
(18.75%)
20.09M
MHNMenhaden Resource Efficiency Plc
148.50p
(18.33%)
1M
ZENZenith Energy Ltd.
2.50p
(16.28%)
3.93M
TRYBTribe Technology Plc
0.115p
(-79.09%)
24.27M
NMTNeometals Ltd
2.75p
(-35.29%)
49.4k
SNGSynairgen Plc
2.46p
(-34.31%)
4.31M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
AYMAnglesey Mining Plc
0.70p
(-17.65%)
2.99M
NTVONativo Resources Plc
0.002p
(5.26%)
971.94M
TRPTower Resources Plc
0.035p
(9.38%)
620.03M
LLOYLloyds Banking Group Plc
54.16p
(-0.26%)
341.48M
ORCPOracle Power Plc
0.0255p
(-1.92%)
192.93M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M

Discussion

View Full Feed
StayHumble StayHumble 4 minutes ago
💹💹💹 https://theqcup.com/patents
HCMC
StayHumble StayHumble 7 minutes ago
💹$HCMC Heading 2Court💹StrongerCase Sufficient 2Disavow $PM💹! @InsidePMI Self Reports of

Less Combustion = No Combustion

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/6436df8d94fa09523deadf45/1681317773824/2023-04-12_HCMC_v_P
HCMC PM
capgain capgain 10 minutes ago
Do we know what was in the bill that passed last night?
StayHumble StayHumble 14 minutes ago
💹infinity incoming in SHORT Order💹Power2 the P1ayers💹💹💹
GME
CorsairNavigator20 CorsairNavigator20 19 minutes ago
What is your purpose on this board? This is a microcap not a large cap. If you are looking for dividends look at JEPQ an ETF that pays around 9% and it uses an .options strategy. Depends on your definition nice yield. Also I do take exception to the slobbering gambling addict since all stock mar
MRKR
hnbadger1 hnbadger1 22 minutes ago
The abstract of the patent application titled
"Therapy Selection and Treatment of Neurodegenerative Disorders" describes a method for individualized therapy selection and monitoring for neurodegenerative disorders. The focus is on using Sigma-1 receptor agonist therapy to treat neurodegenerat
AVXL
CanItBThisEZ2Make CanItBThisEZ2Make 24 minutes ago
BEST SELLERS RANK (BSR) IS 853 69 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Frankestin Frankestin 28 minutes ago
the only weakness is the effect which is below average... I wrote previously... but they are average aspects in the sense that for some it is probably higher and for someone lower than average. The real question to which I cannot find an answer is: what cohen effect do the current remedies have?
TNXP
Wayne R Wayne R 32 minutes ago
Things got complicated since FINRA took charge.

Now companies can say, that is what we filed but that wasn't what we meant, after the fact.

Why they'd even bother with a 1 share roundup is a mystery, unless.., they don't like this company and want to make sure it gets d
VERB
capgain capgain 34 minutes ago
Please hurry!
edbi46 edbi46 37 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any d
MCF WBA
capgain capgain 38 minutes ago
Well, you have that right :)
marcis marcis 39 minutes ago
Bongu ☕️ Happy holidays 🎄

Saturday’s Cafe’ Chat.

$RDAR What market can this company capture or expand on?
It has $45 million, just announced this week, to start work with.

( maybe we should start a new chat board
Cafe
RDAR
glenn1919 glenn1919 42 minutes ago
LTRY.......................https://stockcharts.com/h-sc/ui?s=LTRY&p=W&b=5&g=0&id=p86431144783
LTRY
Wayne R Wayne R 46 minutes ago
Hey, come on by.

On the menu is lasagna with FIVE cheeses!!

I always make too much. It must be because of the genes passed down from my Hungarian grandmother.

She always had something cooking and ready to eat just in case someone came by and was hungry.
Mufaso Mufaso 46 minutes ago
No, VKTX doesn't have an agreement in place with anyone. Brian Lian has said that Viking will announce an agreement with someone by EOY although that could drag on a bit as Viking may have a bit more leverage now that CagriSema looks to be second rate.

I speculated that it is Bachem
VKTX
FanOfspringsteen FanOfspringsteen 54 minutes ago
Yesterday, though roughly 5 minutes before open market , the share price was shown down - 7.6% and -11% half an hour before. I don't know the reason why. 
IDCC
SkeBallLarry SkeBallLarry 55 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 56 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 57 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
prototype_101 prototype_101 58 minutes ago
this new article by Lebby p6-7 leads me to believe that LWLG has suitors despite Lebby desire to stay as standalone

Electro-optic polymers – a revolution in optical switching?

https://online.flippingbook.com/view/660560119/6/
LWLG
SkeBallLarry SkeBallLarry 59 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
shoondale shoondale 1 hour ago
Beside criminality, what qualifications does the bribery felon possess that Johnston and Williams would eagerly anoint him the president of their MedeSol company and then beg the judge to allow him to serve time as their president rather than serve his time to the society he swindled?
https:
MGON
hnbadger1 hnbadger1 1 hour ago
It seems like Anavex has built a proprietary software and diagnostic toolkit for CNS diseases using blarcamesine. They give a patient drug and measure before/after genetic response. They can then diagnose or determine risk for developing CNS diseases.
PERSONALIZED MEDICINE for most CNS diseas
AVXL